Prevalence of diabetes, age-standardized in Myanmar
Myanmar: Prevalence of diabetes, age-standardized was 13.77 in 2022. ▲ Rising
Prevalence of diabetes, age-standardized in Myanmar, 1990–2022
Source: World Health Organization, Global Health Observatory.
Analysis
Myanmar recorded 13.77 for prevalence of diabetes, age-standardized in 2022. That is the highest value across all 33 years on record.
That represents a change of up 4.6% on the previous year and up 50.8% over ten years.
Over the whole period, prevalence of diabetes, age-standardized in Myanmar peaked at 13.77 in 2022 and was at its lowest, 6.67, in 1990.
That places Myanmar 81st out of 198 countries with data for 2022, putting it in the middle of the range.
The long-run direction has been consistently rising across the 33 years of available data.
Prevalence of diabetes, age-standardized in Myanmar, year by year
| Year | Value | Change |
|---|---|---|
| 1990 | 6.67 | — |
| 1991 | 6.72 | +0.7% |
| 1992 | 6.78 | +0.8% |
| 1993 | 6.83 | +0.9% |
| 1994 | 6.9 | +0.9% |
| 1995 | 6.96 | +0.9% |
| 1996 | 7.03 | +0.9% |
| 1997 | 7.09 | +0.9% |
| 1998 | 7.16 | +0.9% |
| 1999 | 7.22 | +0.9% |
| 2000 | 7.29 | +1.0% |
| 2001 | 7.37 | +1.0% |
| 2002 | 7.45 | +1.1% |
| 2003 | 7.54 | +1.2% |
| 2004 | 7.64 | +1.4% |
| 2005 | 7.76 | +1.6% |
| 2006 | 7.9 | +1.8% |
| 2007 | 8.05 | +2.0% |
| 2008 | 8.23 | +2.1% |
| 2009 | 8.42 | +2.3% |
| 2010 | 8.63 | +2.5% |
| 2011 | 8.87 | +2.8% |
| 2012 | 9.14 | +3.0% |
| 2013 | 9.43 | +3.3% |
| 2014 | 9.77 | +3.6% |
| 2015 | 10.15 | +3.9% |
| 2016 | 10.57 | +4.1% |
| 2017 | 11.02 | +4.3% |
| 2018 | 11.51 | +4.4% |
| 2019 | 12.03 | +4.5% |
| 2020 | 12.58 | +4.6% |
| 2021 | 13.16 | +4.6% |
| 2022 | 13.77 | +4.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 6.94 | 6.67 | 7.22 | 10 |
| 2000s | 7.76 | 7.29 | 8.42 | 10 |
| 2010s | 10.11 | 8.63 | 12.03 | 10 |
| 2020s | 13.17 | 12.58 | 13.77 | 3 |
Countries ranked near Myanmar
- 78 Chile 13.98 compare
- 79 Seychelles 13.95 compare
- 80 South Africa 13.86 compare
- 82 North Korea 13.65 compare
- 83 Tuvalu 13.6 compare
- 84 Azerbaijan 13.56 compare
More health data for Myanmar
- Un projection of annual infant deaths, annual growth rate -2.11 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.1576 % change on previous year (2090)
- Heat deaths vs projected death rates 1,398 (2090)
- Un projection of annual infant deaths 2,973 (2100)
- Population ages 0-14, female, annual growth rate -0.2715 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.1172 units per person (2025)
- Population ages 0-14, male, annual growth rate -0.2798 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.1236 units per person (2025)
Frequently asked questions
- What is prevalence of diabetes, age-standardized in Myanmar?
- Prevalence of diabetes, age-standardized in Myanmar was 13.77 in 2022, according to World Health Organization, Global Health Observatory.
- What is the highest prevalence of diabetes, age-standardized recorded in Myanmar?
- The highest recorded value was 13.77 in 2022.
- What is the lowest prevalence of diabetes, age-standardized recorded in Myanmar?
- The lowest recorded value was 6.67 in 1990.
- How does Myanmar rank for prevalence of diabetes, age-standardized?
- Myanmar ranks 81st out of 198 countries with data for 2022.
- Is prevalence of diabetes, age-standardized rising or falling in Myanmar?
- Over the last ten years it is up 50.8%. The long-run trend across the full record is rising.
- Where does this Myanmar data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Prevalence of diabetes, age-standardized. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 33 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).